Drug development strategies for asthma: in search of a new paradigm
- 1 July 2004
- journal article
- Published by Springer Nature in Nature Immunology
- Vol. 5 (7) , 695-698
- https://doi.org/10.1038/ni0704-695
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Interactions between respiratory tract infections and atopy in the aetiology of asthma: Fig. 1.—European Respiratory Journal, 2002
- Allergy development and the intestinal microflora during the first year of lifeJournal of Allergy and Clinical Immunology, 2001
- The health economics of asthma and rhinitis. I. Assessing the economic impactJournal of Allergy and Clinical Immunology, 2001
- Paediatric origins of adult lung diseases bullet 2: Prevention of adult asthma by early intervention during childhood: potential value of new generation immunomodulatory drugsThorax, 2000
- On early sensitization to allergens and development of respiratory symptomsClinical and Experimental Allergy, 1999
- Allergic respiratory disease: strategic targets for primary prevention during childhoodThorax, 1997
- Serum IgE levels, atopy, and asthma in young adults: results from a longitudinal cohort studyAllergy, 1996
- A potential vaccine strategy for asthma and allied atopic diseases during early childhoodThe Lancet, 1994
- Genetic ‘risk’ for atopy is associated with delayed postnatal maturation of T‐cell competenceClinical and Experimental Allergy, 1992
- Tracking of lung function in healthy children and adolescentsPediatric Pulmonology, 1990